Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BlueCrest Capital Management is a prominent global alternative investment management firm founded in 2000 by Michael Platt and William Reeves. Originally established as one of Europe's largest hedge funds, the firm transitioned into a private family office in late 2015, returning outside capital to focus on managing the assets of its partners and employees. Headquartered in Jersey, the firm operates across major financial hubs including London, New York, and Singapore, utilizing sophisticated proprietary trading strategies in fixed income, equities, and commodities. While the firm may invest in healthcare and life science sectors through its equity portfolios, it is not a biotechnology or pharmaceutical company and does not develop therapeutic products or platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BlueCrest Capital Management.